VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $388 | -100.0% | 12,877 | -92.4% | 0.02% | -93.1% |
| Q2 2022 | $4,634,000 | +86.1% | 169,248 | +117.8% | 0.25% | +268.7% |
| Q4 2021 | $2,490,000 | -82.0% | 77,714 | -83.4% | 0.07% | -87.9% |
| Q3 2021 | $13,819,000 | +3084.1% | 468,930 | +4128.0% | 0.56% | +1637.5% |
| Q3 2020 | $434,000 | +33.5% | 11,091 | -21.3% | 0.03% | +77.8% |
| Q1 2020 | $325,000 | -73.7% | 14,098 | -78.9% | 0.02% | -87.5% |
| Q3 2018 | $1,235,000 | -23.3% | 66,690 | -9.0% | 0.14% | +15.2% |
| Q1 2018 | $1,611,000 | -69.4% | 73,289 | -68.0% | 0.12% | -78.0% |
| Q3 2017 | $5,267,000 | +80.6% | 229,385 | +79.4% | 0.57% | +134.3% |
| Q1 2017 | $2,916,000 | +57.1% | 127,835 | +44.1% | 0.24% | +112.3% |
| Q4 2016 | $1,856,000 | -81.5% | 88,702 | -75.5% | 0.11% | -87.0% |
| Q2 2016 | $10,030,000 | – | 362,110 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |